How to improve patient safety in clinical trials?
More than 170.000 persons participate in clinical trials every year worldwide and the global market for clinical trials estimated to 500 billion DKK / year.
This concept aims to improve phase 2-4 trials involving patients who have a need for pills, capsules and tablets + additional OTCs.
A very important part of clinical trials is to eliminate all the factors that are not a part of the treatment, to make the trial so reliable as possible.
But unfortunately the compliance rate is difficult to measure, because it all relies on patient trust. Patients forgets to take their medicine, or the staff forgets to give the right medicine at the right time. Often the medicine is stored incorrectly, increasing the risk of decay, which might have fatal consequences for the patients health, and might be life threatening. This concept aims to improve compliance by using an intelligent day-to-day pill box, that stores the usage of the pillbox and warns the patient and stakeholders during the trials. The concept was created with help from IdemoLab at Delta – part of FORCE Technology, The Danish Medicines Agency and Rigshospitalet.
Thorough user research was a major part of the project, and I conducted interviews and usability tests with the different stakeholders involved to map out pain points, risks and the overall process of a clinical phase-3 trial. At this page I have added some of the infographics from the research phase and mockups of the final solution.